The three azole compounds flubendazole, mebendazole, and fenbendazole inhibited the proliferation and migration of glioma cells in various cell lines and led to pyroptosis of tumor cells via the activation of the nuclear factor kappa-light-chain-enhancer of activated B-cell (NF-kB) complex. The gene discussed is NFKB1; the disease is central nervous system cancer.